- Home
- KNF vs LNTH Comparison
KNF vs LNTH Comparison
Compare KNF & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNF | LNTH |
|---|---|---|
| Founded | 1917 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.9B |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KNF | LNTH |
|---|---|---|
| Price | $74.00 | $76.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $97.38 | $83.20 |
| AVG Volume (30 Days) | 705.0K | ★ 977.5K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.76 | ★ 3.41 |
| Revenue | ★ $3,146,012,000.00 | $343,374,000.00 |
| Revenue This Year | $9.15 | N/A |
| Revenue Next Year | $5.53 | $13.93 |
| P/E Ratio | $29.77 | ★ $22.22 |
| Revenue Growth | ★ 8.52 | 3.62 |
| 52 Week Low | $58.72 | $47.27 |
| 52 Week High | $101.02 | $108.86 |
Technical Indicators
Market Signals| Indicator | KNF | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 38.03 | 50.76 |
| Support Level | $68.72 | $72.33 |
| Resistance Level | $79.11 | $84.77 |
| Average True Range (ATR) | 3.43 | 2.47 |
| MACD | -0.72 | -0.59 |
| Stochastic Oscillator | 2.21 | 38.98 |
Price Performance
Historical ComparisonAbout KNF Knife Riv Holding Co.
Knife River Holding Co is an aggregates-led construction materials and contracting services provider. The segments of the company include West, Mountain, Central, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.